Intersect Ent Inc
NASDAQ:XENT
Intersect Ent Inc
Operating Expenses
Intersect Ent Inc
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Intersect Ent Inc
NASDAQ:XENT
|
Operating Expenses
-$152.8m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Operating Expenses
-$6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-7%
|
|
Boston Scientific Corp
NYSE:BSX
|
Operating Expenses
-$7.7B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-7%
|
|
Stryker Corp
NYSE:SYK
|
Operating Expenses
-$8.9B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-9%
|
|
Abbott Laboratories
NYSE:ABT
|
Operating Expenses
-$15.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-7%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Expenses
-$3B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-14%
|
See Also
What is Intersect Ent Inc's Operating Expenses?
Operating Expenses
-152.8m
USD
Based on the financial report for Mar 31, 2022, Intersect Ent Inc's Operating Expenses amounts to -152.8m USD.
What is Intersect Ent Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-10%
Over the last year, the Operating Expenses growth was -27%. The average annual Operating Expenses growth rates for Intersect Ent Inc have been -9% over the past three years , -10% over the past five years .